Didanosine (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Didanosine drug offered from Teva Pharmaceuticals USA, Inc.. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
NON-PROPRIETARY NAME: | Didanosine |
SUBSTANCE NAME: | DIDANOSINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, DELAYED RELEASE PELLETS |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2004-12-15 |
END MARKETING DATE: | 0000-00-00 |
Didanosine HUMAN PRESCRIPTION DRUG Details:
Item Description | Didanosine from Teva Pharmaceuticals USA, Inc. |
LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/1) |
START MARKETING DATE: | 2004-12-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0555-0588_9afede1b-4832-4807-8b8d-0533f057987f |
PRODUCT NDC: | 0555-0588 |
APPLICATION NUMBER: | ANDA077167 |
Other DIDANOSINE Pharmaceutical Manufacturers / Labelers: